← Back to Search
Tris (dibenzylideneacetone) Dipalladium: A Small-molecule Palladium Complex Is Effective In Inducing Apoptosis In Chronic Lymphocytic Leukemia B-cells
N. Kay, T. Sassoon, C. Secreto, S. Sinha, T. Shanafelt, A. Ghosh, J. Arbiser
Published 2016 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Here we tested impact of Tris (dibenzylideneacetone) dipalladium (Tris-DBA) on chronic lymphocytic leukemia (CLL) B-cell survival. Indeed, treatment of CLL B-cells with Tris-DBA induced apoptosis in a dose-dependent manner irrespective of IgVH mutational status. Further analyses suggest that Tris-DBA-induced apoptosis involves reduced expression of the anti-apoptotic proteins Bcl-xL, and XIAP with an upregulation of the pro-apoptotic protein BIM in CLL B-cells. Our findings also indicate that Tris-DBA targets the ribosomal protein (rp)-S6, an essential component of the Akt/mTOR signaling axis in CLL B-cells. Of interest, CLL bone marrow stromal cells were unable to protect the leukemic B cells from Tris-DBA-induced apoptosis in an in vitro co-culture system. Finally, co-administration of Tris-DBA and the purine nucleoside analog fludarabine (F-ara-A) augmented CLL B-cell apoptosis levels in vitro showing synergistic effects. In total, Tris-DBA is effective at inducing apoptosis in CLL B-cells even in the presence of stromal cells likely by targeting directly the signal mediator, rpS6.
This paper references
Rational approach to the clinical protocol design for drug combinations: a review.
T. Chang (2000)
Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.
I. Ringshausen (2002)
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity
S. Cheng (2014)
Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
Ju-Yoon Yoon (2013)
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.
I. Hazan-Halevy (2010)
Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
W. Ding (2014)
Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".
N. Kay (2007)
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic
W Ding (2010)
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
T. Chou (1984)
Valproic acid enhances fludarabine - induced
Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma
P. de la Puente (2016)
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
A. Ghosh (2011)
Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo
Sulochana S. Bhandarkar (2008)
The tumor suppressor axis p 53 / miR - 34 a regulates Axl expression in B - cell chronic lymphocytic
Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis
J. Zhuang (2014)
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function
K. Jastrzebski (2007)
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
D. Frank (1997)
Regulation of ribosomal protein S6 kinases by ubiquitination.
M. Wang (2008)
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
F. Cervantes-Gomez (2015)
Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.
R. Negro (2012)
The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
J. Boysen (2014)
: implications for therapy in p 53 - defective CLL patients
SW Yu (2014)
VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
Y. Lee (2010)
Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
A. Ghosh (2009)
The mammalian target of rapamycin signaling network and gene regulation. Current opinion in lipidology
GA Soliman (2005)
RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation*
Philippe P Roux (2007)
Regulation and localization of ribosomal protein S6 kinase 1 isoforms
Doyil Kim (2009)
Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death
S. Yu (2006)
Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma
S. Kim (2013)
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.
J. Brown (2014)
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
G. Choudhary (2015)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.
B. Magnuson (2012)
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
W. Ding (2010)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
M. Hallek (2008)
The mammalian target of rapamycin signaling network and gene regulation
Ghada A. Soliman (2005)
The phosphatidylinositol 3‐kinases (PI3K) inhibitor GS‐1101 synergistically potentiates histone deacetylase inhibitor‐induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal‐regulated kinase pathways
J. Bodo (2013)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working
M Hallek (1996)
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.
J. Byrd (2013)
Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation
F. Palacios (2014)
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors
S. Sinha (2015)
The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
S. Fiorcari (2013)
STAT3-Activated GM-CSFRα Translocates to the Nucleus and Protects CLL Cells from Apoptosis
P. Li (2014)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. The Biochemical journal
B Magnuson (2012)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.
A. Ghosh (2009)
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
U. Rozovski (2014)
ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats
L. Hu (2010)
Ribosomal Protein S6, a Target of Rapamycin, Is Involved in the Regulation of rRNA Genes by Possible Epigenetic Changes in Arabidopsis *
Y. Kim (2013)
This paper is referenced by
Tris DBA Ameliorates Accelerated and Severe Lupus Nephritis in Mice by Activating Regulatory T Cells and Autophagy and Inhibiting the NLRP3 Inflammasome
Chung-Yao Wu (2020)
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo
Elgilda Musi (2019)
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines
T. Scattolin (2019)
Palladium based nanoparticles for the treatment of advanced melanoma
J. Elsey (2019)
Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy
M. Qiu (2018)
Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1‐ and SIRT3‐mediated autophagy induction
Chung-Yao Wu (2020)
Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases
W. Kallemeijn (2019)